GeminIQ Website Logo

Viewing ABEO free

Subscribe for full history, 50+ metrics, screener, watchlist...

ABEONA THERAPEUTICS INC.

ABEO

Companies in Pharmaceutical Preparations

ABEONA THERAPEUTICS INC. (ABEO) — SEC Financial Statements & Analysis

ABEONA THERAPEUTICS INC. (ABEO) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
61788316416231634181456
Short Term Investments
107113124626874948845384931
Restricted Cash
--0000000000
Accounts Receivable Net Current
66---------4
Inventory Net
6553--------
Other Receivables Net Current
112222222222
Prepaid Expense And Other Assets Current
212221112111
Assets Current
1832052162328810111312667565744
Property Plant And Equipment Net
111010974444444
Operating Lease Right Of Use Asset
444444444455
Other Assets
----------00
Other Assets Noncurrent
1110000000--
Assets
1982202312469910912113475646654
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
486753333233
Accrued Liabilities Current
587546553644
Long Term Debt Current
1312968642----
Operating Lease Liability Current
110111121122
Other Loans Payable Current
--------55--
Accrued Income Taxes Current
00016--------
Other Liabilities Current
-00000000000
Liabilities Current
3130223518171817121389
Operating Lease Liability Noncurrent
444443334444
Long Term Debt Noncurrent
5811141113141618---
Derivative Liabilities Noncurrent
-------11---
Contract With Customer Liability Noncurrent
0-----------
Derivative Liabilities
1419---32------
Liabilities
546060835865756184494444
Stockholders Equity
Common Stock Value
111100000000
Additional Paid In Capital
904901892880866857849847772764755730
Retained Earnings Accumulated Deficit
-759-742-722-716-825-813-804-774-781-750-733-721
Accumulated Other Comprehensive Income Loss Net Of…
-000-0-00-0-0-0-0-0-0
Stockholders Equity
14515917116441444673-915229
Liabilities And Stockholders Equity
1982202312469910912113475646654
Preferred Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Preferred Stock Shares Authorized
222222222222
Preferred Stock Shares Issued
000000000000
Preferred Stock Shares Outstanding
000000000000
Common Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Common Stock Shares Authorized
200200200200200200200200200200200200
Common Stock Shares Issued
227220210205196183174167165159148150
Shares Outstanding
575552514946434228272521

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-4.38%12.08%----------
202516.41%1.73%12.09%-4.70%-25.17%-33.47%-1.42%7.49%3.04%3.15%23.95%14.71%
2024-9.34%-3.61%-0.21%12.12%30.51%26.26%1.34%1.18%-6.89%-10.51%2.53%31.13%
2023---40.60%41.28%24.50%6.22%25.78%-1.78%8.01%-39.91%-38.91%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
5.89
6.93
9.74
6.73
4.90
6.08
6.12
7.48
5.61
4.15
6.81
4.67
Quick Ratio
5.64
6.70
9.43
6.59
4.79
6.01
6.06
7.40
5.46
4.10
6.69
4.54
Working Capital
151.94M
175.34M
193.95M
197.75M
70.14M
84.27M
94.24M
109.06M
54.84M
42.32M
48.85M
34.60M
Leverage & Debt
Debt to Equity
0.37
0.38
0.35
0.51
1.40
1.47
1.63
0.83
-9.43
3.32
2.00
4.73
Interest Coverage TTM
-25.97
-23.92
-21.13
-18.01
-16.36
-15.26
-18.78
-25.35
-38.95
-112.76
-96.23
-83.32
Debt Ratio
0.27
0.27
0.26
0.34
0.58
0.60
0.62
0.45
1.12
0.77
0.67
0.83
Efficiency & Turnover
Asset Turnover TTM
0.10
0.04
0.02
0.02
0.05
0.05
-0.00
0.02
0.07
0.06
0.12
0.08
Days Sales Outstanding TTM
155.64
314.68
-
-
-
-
-
-
-
-
-
208.86
Receivables Turnover TTM
2.35
1.16
-
-
-
-
-
-
-
-
-
1.75
Per Share Metrics
Diluted EPS TTM
1.17
1.08
1.52
0.86
-0.89
-1.55
-1.48
-1.03
-1.40
-0.63
-0.60
-0.55
Free Cash Flow Per Share TTM
-1.51
-1.59
-1.52
-1.36
-1.27
-1.42
-1.05
-1.09
-1.49
-1.75
-1.70
-2.39
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
77.50%
105.93%
181.36%
205.53%
190.26%
199.11%
-1,067.87%
210.03%
129.22%
110.82%
108.00%
113.71%
Operating Profit Margin TTM
-637.92%
-1,254.53%
-2,655.89%
-1,900.46%
-1,476.94%
-1,512.27%
21,930.69%
-2,789.43%
-1,138.08%
-1,219.85%
-770.00%
-1,142.12%
Net Profit Margin TTM
454.86%
998.36%
2,628.47%
1,459.51%
-937.51%
-1,501.04%
25,643.32%
-2,585.99%
-1,765.12%
-1,402.38%
-734.77%
-999.90%
Growth Metrics
Net Revenue Growth (1Y)
208.51%
67.92%
-1,231.05%
92.82%
8.52%
9.89%
-104.55%
-48.27%
203.28%
173.27%
123.34%
183.69%
Net Income Growth (1Y)
-249.68%
-211.69%
-215.93%
-208.83%
-42.36%
17.62%
58.84%
33.79%
186.48%
36.51%
-43.58%
-50.77%
EPS Growth (1Y)
-231.59%
-186.58%
-202.77%
-182.90%
-68.37%
-38.74%
-18.08%
-39.75%
77.29%
0.39%
-70.78%
-68.27%
Valuation Metrics
P/E TTM
3.84
3.92
3.48
5.21
-5.36
-3.59
-4.28
-3.23
-2.58
-1.98
-2.33
-1.85
P/B
1.75
1.75
1.67
1.82
5.72
5.19
6.64
2.32
-22.30
7.22
4.74
7.77
P/S TTM
17.45
39.14
91.41
76.07
50.28
53.85
-1,097.03
83.40
45.60
27.72
17.15
18.47
Market Cap
253.66M
279.06M
286.40M
298.34M
236.95M
228.64M
303.88M
169.64M
198.04M
107.12M
104.40M
72.61M
Enterprise Value
210.37M
220.66M
222.93M
154.03M
239.96M
224.24M
306.46M
153.24M
198.56M
108.60M
99.35M
66.39M
Calculated Values
Free Cash Flow TTM
-85.24M
-84.30M
-82.36M
-71.29M
-63.00M
-58.46M
-50.57M
-43.72M
-40.64M
-37.34M
-42.09M
-43.09M
Net Debt
-43.29M
-58.40M
-63.47M
-144.31M
3.01M
-4.39M
2.59M
-16.41M
521.00K
1.48M
-5.05M
-6.23M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-06-15Sale
Owner: Silverstein, Christine Be…
Title: -
Shares: 18,160
Price/Share: $5.71
Value: $103,693.60
Shares Owned: 119,562
Relationship: Director
Ownership: Direct
2026-06-09Sale
Owner: O'Malley, Brendan M.
Title: SVP, Chief Legal Officer
Shares: 6,305
Price/Share: $5.30
Value: $33,416.50
Shares Owned: 440,003
Relationship: Officer
Ownership: Direct
2026-06-09Sale
Owner: Seshadri, Vishwas
Title: Chief Executive Officer
Shares: 31,916
Price/Share: $5.30
Value: $169,154.80
Shares Owned: 1,374,079
Relationship: Director,Officer
Ownership: Direct
2026-06-09Sale
Owner: Vasanthavada, Madhav
Title: Chief Commercial Officer
Shares: 5,450
Price/Share: $5.30
Value: $28,885.00
Shares Owned: 303,451
Relationship: Officer
Ownership: Direct
2026-06-09Sale
Owner: Vazzano, Joseph Walter
Title: Chief Financial Officer
Shares: 39,067
Price/Share: $5.34
Value: $208,617.78
Shares Owned: 518,437
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
69.23%
Inst. Shares: 39,199,978
Shares Outstanding: 56,620,920
2025-12-31
73.45%
Inst. Shares: 38,896,199
Shares Outstanding: 52,952,917
2025-09-30
65.49%
Inst. Shares: 35,525,513
Shares Outstanding: 54,242,507
2025-06-30
66.08%
Inst. Shares: 34,705,806
Shares Outstanding: 52,524,510
2025-03-31
59.07%
Inst. Shares: 29,402,046
Shares Outstanding: 49,778,801

Research Faster.
Invest Smarter.

ABEONA THERAPEUTICS INC. (ABEO) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.